Dr Ruby Anne Deveras, MD | |
303 N Clyde Morris Blvd, Halifax Regional Oncology Center, Daytona Beach, FL 32114-2709 | |
(386) 254-4212 | |
(386) 254-4214 |
Full Name | Dr Ruby Anne Deveras |
---|---|
Gender | Female |
Speciality | Medical Oncology |
Experience | 28 Years |
Location | 303 N Clyde Morris Blvd, Daytona Beach, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306844360 | NPI | - | NPPES |
273856200 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | ME75526 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Halifax Health Medical Center | Daytona beach, FL | Hospital |
Adventhealth New Smyrna Beach | New smyrna beach, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Halifax Healthcare Systems Inc | 1254238090 | 278 |
News Archive
Also in the news, the Pentagon is in search of a new system for veterans' health care while San Francisco is "leading the way" in new health data applications.
ev3 Inc., a global endovascular device company, today reported financial results for its fiscal first quarter and updated financial guidance for 2010. ev3's net sales totaled $123.9 million in the first quarter of 2010 compared to $100.4 million in the same quarter of the prior year. Excluding $2.9 million of positive impact due to foreign currency exchange rates, net sales increased 21% versus the prior year quarter.
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
› Verified 1 days ago
Entity Name | Halifax Healthcare Systems Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245283530 PECOS PAC ID: 1254238090 Enrollment ID: O20031218000443 |
News Archive
Also in the news, the Pentagon is in search of a new system for veterans' health care while San Francisco is "leading the way" in new health data applications.
ev3 Inc., a global endovascular device company, today reported financial results for its fiscal first quarter and updated financial guidance for 2010. ev3's net sales totaled $123.9 million in the first quarter of 2010 compared to $100.4 million in the same quarter of the prior year. Excluding $2.9 million of positive impact due to foreign currency exchange rates, net sales increased 21% versus the prior year quarter.
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ruby Anne Deveras, MD 303 N Clyde Morris Blvd, Halifax Regional Oncology Center, Daytona Beach, FL 32114-2709 Ph: (386) 254-4212 | Dr Ruby Anne Deveras, MD 303 N Clyde Morris Blvd, Halifax Regional Oncology Center, Daytona Beach, FL 32114-2709 Ph: (386) 254-4212 |
News Archive
Also in the news, the Pentagon is in search of a new system for veterans' health care while San Francisco is "leading the way" in new health data applications.
ev3 Inc., a global endovascular device company, today reported financial results for its fiscal first quarter and updated financial guidance for 2010. ev3's net sales totaled $123.9 million in the first quarter of 2010 compared to $100.4 million in the same quarter of the prior year. Excluding $2.9 million of positive impact due to foreign currency exchange rates, net sales increased 21% versus the prior year quarter.
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
› Verified 1 days ago
Dr. Richard Carl Weiss, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Halifax Regional Oncology Center, Daytona Beach, FL 32114 Phone: 386-254-4212 Fax: 386-254-4214 | |
Dhrumil Vijaykumar Patel, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 301 Memorial Medical Pkwy, Daytona Beach, FL 32117 Phone: 386-231-1091 Fax: 386-231-1092 | |
Alexandra Crossman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-589-5741 | |
Dr. Vinicius Costa Diniz Domingues, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 709 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 347-543-1232 Fax: 347-543-1232 | |
Dr. David Scott Weinreich, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 731 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-257-1626 Fax: 866-899-3686 | |
Dr. Nashwa Marie Wahba, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 810 Wildwood St, Suite 1, Daytona Beach, FL 32117 Phone: 386-258-7100 Fax: 386-253-1843 | |
Ms. Delinda Demita Wills, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd., Halifax Health Medical Center, Daytona Beach, FL 32114 Phone: 386-254-4152 Fax: 386-254-4315 |